DAX23.116 -0,6%ESt505.230 -0,6%Top 10 Crypto12,70 +1,6%Dow41.114 +0,7%Nas17.738 +0,3%Bitcoin87.246 +1,6%Euro1,1328 +0,1%Öl61,54 +1,0%Gold3.399 +1,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 RENK RENK73 Novo Nordisk A3EU6F Lufthansa 823212 Mercedes-Benz Group (ex Daimler) 710000 HENSOLDT HAG000 Palantir A2QA4J Allianz 840400 Tesla A1CX3T BASF BASF11 Siemens Energy ENER6Y Deutsche Bank 514000 Vonovia A1ML7J Commerzbank CBK100
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX schließt im Minus -- US-Börsen schließen fester -- Fed lässt Leitzins stabil -- Super Micro enttäuscht bei Umsatz -- Novo Nordisk senkt Ziele -- HENSOLDT, BMW, AMD, NVIDIA, Uber, Disney im Fokus
Top News
Ray Dalio warnt vor Zusammenbruch globaler Ordnung - US-Wirtschaft leide unter Trumps Zollpolitik Ray Dalio warnt vor Zusammenbruch globaler Ordnung - US-Wirtschaft leide unter Trumps Zollpolitik
Standard Chartered sieht Bitcoin-Rally: Neues Allzeithoch noch im Sommer möglich Standard Chartered sieht Bitcoin-Rally: Neues Allzeithoch noch im Sommer möglich
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

EQS-Adhoc: Change of President and CEO at Carl Zeiss Meditec AG

07.05.25 14:36 Uhr
Werte in diesem Artikel
Aktien
Carl Zeiss Meditec AG
58,15 EUR -1,70 EUR -2,84%
Charts|News|Analysen
Aktie kaufen

EQS-Ad-hoc: Carl Zeiss Meditec AG / Key word(s): Personnel
Change of President and CEO at Carl Zeiss Meditec AG

07-May-2025 / 14:36 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Wer­bung

Change of President and CEO at Carl Zeiss Meditec AG
 
Jena, May 7, 2025

The supervisory board of Carl Zeiss Meditec AG (ISIN: DE0005313704) in today’s meeting has agreed on a change in the Management Board of the company. Dr. Markus Weber, President and CEO of Carl Zeiss Meditec AG since January 1, 2022, will turn over his position to Maximilian Foerst, currently Head of ZEISS Greater China, on May 31, 2025. The handover is taking place at Dr. Weber’s own request and on best of terms with the Supervisory Board.

Maximilian Foerst joined Carl Zeiss AG in 1995 and, following initial roles in product management and marketing in the medical technology field, took over leadership of the Carl Zeiss sales and service companies in France and Korea and – since 2009 - ZEISS Greater China. Under his leadership, ZEISS achieved market leadership in the Refractive Laser business as well as a leading position in the intraocular lense business in China. The region Greater China is the largest single market for Carl Zeiss Meditec AG with a revenue share of 26% in fiscal year 2023/24.

Along with his new role as President and CEO of Carl Zeiss Meditec AG, Maximilian Foerst has also been nominated as an Executive Board member of Carl Zeiss AG and will take over Dr. Weber’s responsibilities. Dr. Weber will leave the Executive Board of Carl Zeiss AG likewise on May 31, 2025.

In the view of the Supervisory Board of Carl Zeiss Meditec AG, management continuity is assured via the internal succession. The Chief Financial Officer, Justus Felix Wehmer remains in office. Leadership of the Strategic Business Units Ophthalmology and Microsurgery remains unchanged as well.
 

 Contact for investors and press

Sebastian Frericks
Head of Group Finance & Investor Relations
Carl Zeiss Meditec AG
Tel.: +49 3641 220-116
E-Mail: investors.med@zeiss.com

 

 

 

 

 

 

 

Wer­bung

 

 



End of Inside Information

07-May-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
Language: English
Company: Carl Zeiss Meditec AG
Göschwitzer Str. 51-52
07745 Jena, Germany
Germany
Phone: +49 (0)3641 220-0
Fax: +49 (0)3641 220-112
E-mail: investors.meditec@zeiss.com
Internet: www.zeiss.de/meditec-ag/ir
ISIN: DE0005313704
WKN: 531370
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2132254

 
End of Announcement EQS News Service

2132254  07-May-2025 CET/CEST

Ausgewählte Hebelprodukte auf Carl Zeiss Meditec

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Carl Zeiss Meditec

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Carl Zeiss Meditec AG

DatumMeistgelesen
Wer­bung

Analysen zu Carl Zeiss Meditec AG

DatumRatingAnalyst
07.05.2025Carl Zeiss Meditec OutperformBernstein Research
07.05.2025Carl Zeiss Meditec UnderweightJP Morgan Chase & Co.
16.04.2025Carl Zeiss Meditec BuyHauck Aufhäuser Lampe Privatbank AG
16.04.2025Carl Zeiss Meditec OutperformBernstein Research
16.04.2025Carl Zeiss Meditec BuyGoldman Sachs Group Inc.
DatumRatingAnalyst
07.05.2025Carl Zeiss Meditec OutperformBernstein Research
16.04.2025Carl Zeiss Meditec BuyHauck Aufhäuser Lampe Privatbank AG
16.04.2025Carl Zeiss Meditec OutperformBernstein Research
16.04.2025Carl Zeiss Meditec BuyGoldman Sachs Group Inc.
15.04.2025Carl Zeiss Meditec OutperformBernstein Research
DatumRatingAnalyst
15.04.2025Carl Zeiss Meditec Sector PerformRBC Capital Markets
11.04.2025Carl Zeiss Meditec Sector PerformRBC Capital Markets
04.04.2025Carl Zeiss Meditec Sector PerformRBC Capital Markets
17.02.2025Carl Zeiss Meditec NeutralUBS AG
14.02.2025Carl Zeiss Meditec Sector PerformRBC Capital Markets
DatumRatingAnalyst
07.05.2025Carl Zeiss Meditec UnderweightJP Morgan Chase & Co.
15.04.2025Carl Zeiss Meditec UnderweightJP Morgan Chase & Co.
13.03.2025Carl Zeiss Meditec UnderweightJP Morgan Chase & Co.
10.03.2025Carl Zeiss Meditec UnderweightJP Morgan Chase & Co.
13.02.2025Carl Zeiss Meditec UnderweightJP Morgan Chase & Co.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Carl Zeiss Meditec AG nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen